VectivBio Holding, a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare gastrointestinal conditions, and Ironwood Pharmaceuticals, a GI-focused healthcare company, announced that they had entered into an agreement for Ironwood to launch an